ADVANCED MALIGNANT SOLID TUMORS
Clinical trials for ADVANCED MALIGNANT SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA vaccine aims to boost immune attack on Hard-to-Treat cancers
Disease control Not yet recruitingThis early-stage trial tests a therapeutic mRNA vaccine designed to target cancer-associated fibroblasts (CAFs) in patients with advanced solid tumors that have not responded to standard treatments. The vaccine works by helping the immune system recognize and attack these support…
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 17, 2026 03:09 UTC
-
New hope for advanced cancer: TPD3310 enters first human trials
Disease control Not yet recruitingThis early-stage study tests a new drug called TPD3310 in about 112 people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and check for any early signs that the drug can shrink tumors. Participants will receive th…
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1 • Sponsor: TAIBIDI PHARMACEUTICAL TECHNOLOGY(SHIJIAZHUANG) CO.,LTD. • Aim: Disease control
Last updated May 17, 2026 02:59 UTC
-
New drug AK150 enters first human tests for advanced cancers
Disease control Not yet recruitingThis early-phase study tests a new drug called AK150 in about 96 people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety and find the right dose. Researchers will also look at how the drug moves through the b…
Matched conditions: ADVANCED MALIGNANT SOLID TUMORS
Phase: PHASE1 • Sponsor: Akeso • Aim: Disease control
Last updated May 14, 2026 12:05 UTC